Angiotensin II upregulates the expression of placental growth factor in human vascular endothelial cells and smooth muscle cells

BMC Cell Biology

Volumn 11, Issue , 2010, Pages

  Pan, Pingxi ^a   Fu, Hua ^a   Zhang, Lingjun ^a   Huang, He ^a   Luo, Fengming ^a   Wu, Wenchao ^a   Guo, Yingqiang ^a   Liu, Xiaojing ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; LOSARTAN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PLACENTAL GROWTH FACTOR; PROTEIN KINASE C; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BLOCKING ANTIBODY; PLACENTA PROTEIN;

ARTICLE; ATHEROSCLEROSIS; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULITIS; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIBODIES, BLOCKING; ATHEROSCLEROSIS; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCYTES, SMOOTH MUSCLE; PREGNANCY PROTEINS; PROTEIN KINASE C; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 77952634073     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-11-36     Document Type: Article

References (44)

1. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999, 340(2):115-126. 10.1056/NEJM199901143400207, 9887164.
2. Libby P, Ridker PM, Maseri A. Inflammation and Atherosclerosis. Circulation 2002, 105(9):1135-1143. 10.1161/hc0902.104353, 11877368.
3. Kranzhofer R, Schmidt J, Pfeiffer CA, Hagl S, Libby P, Kubler W. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999, 19(7):1623-1629.
4. Weiss D, Sorescu D, Taylor W. Angiotensin II and atherosclerosis. The American journal of cardiology 2001, 87(8 A):25-32.
5. Prasad A, Koh KK, Schenke WH, Mincemoyer R, Csako G, Fleischer TA, Brown M, Selvaggi TA, Quyyumi AA. Role of angiotensin II type 1 receptor in the regulation of cellular adhesion molecules in atherosclerosis. Am Heart J 2001, 142(2):248-253. 10.1067/mhj.2001.116699, 11479463.
6. Souza HP, Frediani D, Cobra AL, Moretti AI, Jurado MC, Fernandes TR, Cardounel AJ, Zweier JL, Tostes RC. Angiotensin II modulates CD40 expression in vascular smooth muscle cells. Clin Sci (Lond) 2009, 116(5):423-431. 10.1042/CS20080155, 18785879.
7. Takata Y, Liu J, Yin F, Collins AR, Lyon CJ, Lee CH, Atkins AR, Downes M, Barish GD, Evans RM, Hsueh WA, Tangirala RK. PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(11):4277-4282. 10.1073/pnas.0708647105, 2393800, 18337495.
8. Billet S, Aguilar F, Baudry C, Clauser E. Role of angiotensin II AT1 receptor activation in cardiovascular diseases. Kidney Int 2008, 74(11):1379-1384. 10.1038/ki.2008.358, 18650793.
9. Jones ES, Vinh A, McCarthy CA, Gaspari TA, Widdop RE. AT2 receptors: functional relevance in cardiovascular disease. Pharmacol Ther 2008, 120(3):292-316. 10.1016/j.pharmthera.2008.08.009, 18804122.
10. Alexis JD, Wang N, Che W, Lerner-Marmarosh N, Sahni A, Korshunov VA, Zou Y, Ding B, Yan C, Berk BC, Abe J. Bcr kinase activation by angiotensin II inhibits peroxisome-proliferator-activated receptor gamma transcriptional activity in vascular smooth muscle cells. Circ Res 2009, 104(1):69-78. 10.1161/CIRCRESAHA.108.188409, 2642522, 19023129.
11. Khurana R, Moons L, Shafi S, Luttun A, Collen D, Martin JF, Carmeliet P, Zachary IC. Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation. Circulation 2005, 111(21):2828-2836. 10.1161/CIRCULATIONAHA.104.495887, 15911697.
12. Pilarczyk K, Sattler KJE, Galili O, Versari D, Olson ML, Meyer FB, Zhu XY, Lerman LO, Lerman A. Placenta growth factor expression in human atherosclerotic carotid plaques is related to plaque destabilization. Atherosclerosis 2008, 196(1):333-340. 10.1016/j.atherosclerosis.2006.10.038, 17157858.
13. Lenderink T, Heeschen C, Fichtlscherer S, Dimmeler S, Hamm CW, Zeiher AM, Simoons ML, Boersma E. Elevated Placental Growth Factor Levels Are Associated With Adverse Outcomes at Four-Year Follow-Up in Patients With Acute Coronary Syndromes. Journal of the American College of Cardiology 2006, 47(2):307-311. 10.1016/j.jacc.2005.08.063, 16412852.
14. Errico M, Riccioni T, Iyer S, Pisano C, Acharya KR, Persico MG, De Falco S. Identification of Placenta Growth Factor Determinants for Binding and Activation of Flt-1 Receptor. J Biol Chem 2004, 279(42):43929-43939. 10.1074/jbc.M401418200, 15272021.
15. Yoo SA, Yoon HJ, Kim HS, Chae CB, De Falco S, Cho CS, Kim WU. Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation. Arthritis Rheum 2009, 60(2):345-354. 10.1002/art.24289, 19180491.
16. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Persico MG. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001, 7(5):575-583. 10.1038/87904, 11329059.
17. Heeschen C, Dimmeler S, Fichtlscherer S, Hamm CW, Berger J, Simoons ML, Zeiher AM. Prognostic value of placental growth factor in patients with acute chest pain. JAMA 2004, 291(4):435-441. 10.1001/jama.291.4.435, 14747500.
18. Torry RJ, Tomanek RJ, Zheng W, Miller SJ, Labarrere CA, Torry DS. Hypoxia increases placenta growth factor expression in human myocardium and cultured neonatal rat cardiomyocytes. J Heart Lung Transplant 2009, 28(2):183-190. 10.1016/j.healun.2008.11.917, 19201345.
19. Cramer M, Nagy I, Murphy BJ, Gassmann M, Hottiger MO, Georgiev O, Schaffner W. NF-kappaB contributes to transcription of placenta growth factor and interacts with metal responsive transcription factor-1 in hypoxic human cells. Biol Chem 2005, 386(9):865-872. 10.1515/BC.2005.101, 16164411.
20. Steinkamp-Fenske K, Bollinger L, Voller N, Xu H, Yao Y, Bauer R, Forstermann U, Li H. Ursolic acid from the Chinese herb danshen (Salvia miltiorrhiza L.) upregulates eNOS and downregulates Nox4 expression in human endothelial cells. Atherosclerosis 2007, 195(1):e104-111. 10.1016/j.atherosclerosis.2007.03.028, 17481637.
21. Xu H, Goettsch C, Xia N, Horke S, Morawietz H, Forstermann U, Li H. Differential roles of PKCalpha and PKCepsilon in controlling the gene expression of Nox4 in human endothelial cells. Free Radic Biol Med 2008, 44(8):1656-1667. 10.1016/j.freeradbiomed.2008.01.023, 18291120.
22. Cairrao E, Santos-Silva AJ, Alvarez E, Correia I, Verde I. Isolation and culture of human umbilical artery smooth muscle cells expressing functional calcium channels. In Vitro Cell Dev Biol Anim 2009, 45(3-4):175-184. 10.1007/s11626-008-9161-6, 19118440.
23. de Llano Martin JJ, Fuertes G, Torro I, Garcia Vicent C, Fayos JL, Lurbe E. Birth weight and characteristics of endothelial and smooth muscle cell cultures from human umbilical cord vessels. J Transl Med 2009, 7:30. 10.1186/1479-5876-7-30, 2680391, 19393064.
24. Zhao Q, Ishibashi M, Hiasa K, Tan C, Takeshita A, Egashira K. Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling. Hypertension 2004, 44(3):264-270. 10.1161/01.HYP.0000138688.78906.6b, 15262905.
25. Kitayama H, Maeshima Y, Takazawa Y, Yamamoto Y, Wu Y, Ichinose K, Hirokoshi K, Sugiyama H, Yamasaki Y, Makino H. Regulation of angiogenic factors in angiotensin II infusion model in association with tubulointerstitial injuries. Am J Hypertens 2006, 19(7):718-727. 10.1016/j.amjhyper.2005.09.022, 16814127.
26. Wang Y, Yan T, Wang Q, Wang W, Xu J, Wu X, Ji H. PKC-dependent extracellular signal-regulated kinase 1/2 pathway is involved in the inhibition of Ib on AngiotensinII-induced proliferation of vascular smooth muscle cells. Biochem Biophys Res Commun 2008, 375(1):151-155. 10.1016/j.bbrc.2008.07.137, 18687307.
27. Ge X, Low B, Liang M, Fu J. Angiotensin II directly triggers endothelial exocytosis via protein kinase C-dependent protein kinase D2 activation. J Pharmacol Sci 2007, 105(2):168-176. 10.1254/jphs.FP0070858, 17951978.
28. Jimenez E, de la Blanca Perez E, Urso L, Gonzalez I, Salas J, Montiel M. Angiotensin II induces MMP 2 activity via FAK/JNK pathway in human endothelial cells. Biochem Biophys Res Commun 2009, 380(4):769-774. 10.1016/j.bbrc.2009.01.142, 19338750.
29. Liu L, Wen T, Zheng XY, Yang DG, Zhao SP, Xu DY, Lu GH. Remnant-like particles accelerate endothelial progenitor cells senescence and induce cellular dysfunction via an oxidative mechanism. Atherosclerosis 2009, 202(2):405-414. 10.1016/j.atherosclerosis.2008.05.024, 18582890.
30. Wang QR, Wang F, Zhu WB, Lei J, Huang YH, Wang BH, Yan Q. GM-CSF accelerates proliferation of endothelial progenitor cells from murine bone marrow mononuclear cells in vitro. Cytokine 2009, 45(3):174-178. 10.1016/j.cyto.2008.12.002, 19147372.
31. Herr D, Rodewald M, Fraser HM, Hack G, Konrad R, Kreienberg R, Wulff C. Regulation of endothelial proliferation by the renin-angiotensin system in human umbilical vein endothelial cells. Reproduction 2008, 136(1):125-130. 10.1530/REP-07-0374, 18390690.
32. He M, Han M, Zheng B, Shu YN, Wen JK. Angiotensin II stimulates KLF5 phosphorylation and its interaction with c-Jun leading to suppression of p21 expression in vascular smooth muscle cells. J Biochem 2009, 146(5):683-691. 10.1093/jb/mvp115, 19628677.
33. Geng J, Zhao Z, Kang W, Wang W, Liu G, Sun Y, Zhang Y, Ge Z. Hypertrophic response to angiotensin II is mediated by protein kinase D-extracellular signal-regulated kinase 5 pathway in human aortic smooth muscle cells. Biochem Biophys Res Commun 2009, 388(3):517-522. 10.1016/j.bbrc.2009.08.025, 19666008.
34. Su KH, Tsai JY, Kou YR, Chiang AN, Hsiao SH, Wu YL, Hou HH, Pan CC, Shyue SK, Lee TS. Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling. Cardiovasc Res 2009, 82(3):468-475.
35. Iyer S, Acharya KR. Role of placenta growth factor in cardiovascular health. Trends Cardiovasc Med 2002, 12(3):128-134. 10.1016/S1050-1738(01)00164-5, 12007738.
36. Selvaraj SK, Giri RK, Perelman N, Johnson C, Malik P, Kalra VK. Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood 2003, 102(4):1515-1524. 10.1182/blood-2002-11-3423, 12689930.
37. Oura H, Bertoncini J, Velasco P, Brown LF, Carmeliet P, Detmar M. A critical role of placental growth factor in the induction of inflammation and edema formation. Blood 2003, 101(2):560-567. 10.1182/blood-2002-05-1516, 12393422.
38. Ling S, Dai A, Ma YH, Wilson E, Chatterjee K, Ives HE, Sudhir K. Matrix-dependent gene expression of egr-1 and PDGF A regulate angiotensin II-induced proliferation in human vascular smooth muscle cells. Hypertension 1999, 34(5):1141-1146.
39. Kuma S, Oki E, Onohara T, Komori K, Maehara Y. Angiotensin II-induced growth of vascular smooth muscle cells is associated with modulation of cell surface area and platelet-derived growth factor receptor expression. Clin Exp Pharmacol Physiol 2007, 34(3):153-160. 10.1111/j.1440-1681.2007.04535.x, 17250632.
40. Rudijanto A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med Indones 2007, 39(2):86-93.
41. Clarke M, Bennett M. The emerging role of vascular smooth muscle cell apoptosis in atherosclerosis and plaque stability. Am J Nephrol 2006, 26(6):531-535. 10.1159/000097815, 17159340.
42. Bellik L, Vinci MC, Filippi S, Ledda F, Parenti A. Intracellular pathways triggered by the selective FLT-1-agonist placental growth factor in vascular smooth muscle cells exposed to hypoxia. Br J Pharmacol 2005, 146(4):568-575. 10.1038/sj.bjp.0706347, 1751184, 16086034.
43. Araki-Taguchi M, Nomura S, Ino K, Sumigama S, Yamamoto E, Kotani-Ito T, Hayakawa H, Kajiyama H, Shibata K, Itakura A, Kikkawa F. Angiotensin II mimics the hypoxic effect on regulating trophoblast proliferation and differentiation in human placental explant cultures. Life Sci 2008, 82(1-2):59-67. 10.1016/j.lfs.2007.10.017, 18048061.
44. Mohammed KA, Nasreen N, Tepper RS, Antony VB. Cyclic stretch induces PlGF expression in bronchial airway epithelial cells via nitric oxide release. Am J Physiol Lung Cell Mol Physiol 2007, 292(2):L559-566. 10.1152/ajplung.00075.2006, 17028267.